Evidence map›Paper›PMID 28654734›Full record

ArticleThe American journal on addictions2017

Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity?

Eduardo Roque Butelman, Silvia Bacciardi, Angelo Giovanni Icro Maremmani, Maya Darst-Campbell, Joel Correa da Rosa, Mary Jeanne Kreek

Open access · greenAbstract read
In one paragraph

Article in The American journal on addictions, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Eduardo Roque ButelmanLaboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York.ORCID http://orcid.org/0000-0003-4376-0117
Silvia Bacciardi"VP Dole" Dual Diagnosis Unit, Santa Chiara University Hospital of Pisa, Pisa, Italy.
Angelo Giovanni Icro Maremmani"VP Dole" Dual Diagnosis Unit, Santa Chiara University Hospital of Pisa, Pisa, Italy.
Maya Darst-CampbellLaboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York.
Joel Correa da RosaCenter for Clinical and Translational Science, The Rockefeller University Hospital, New York, New York.
Mary Jeanne KreekLaboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York.
Rockefeller University · USAzienda Ospedaliera Universitaria Pisana · ITRockefeller University Hospital · US

Funding

TRANSFORMING TRANSLATIONAL SCIENCE AND EDUCATION TO BENEFIT HUMAN HEALTHUL1RR024143 · NCRR · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2006 to 2011
$49.1M
WOUND HEALING IN INDIVIDUALS OF DIFFERENT AGE AND GENETIC BACKGROUNDM01RR000102 · NCRR · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 1985 to 2006
$32.8M
ULTRASTUCTURE, RECEPTORS, AND GENE EXPRESSIONP60DA005130 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 2002 to 2012
$30.6M
Transforming Translational Science and Education to Benefit Human HealthUL1TR000043 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2012 to 2015
$26.8M
UNIQUE RNA STRUCTURE OF CAUSATIVE AGENT FOR DELTA HEPATITISP50DA005130 · NIDA · ROCKEFELLER UNIVERSITY · PI YU, JUN · 1987 to 2001
$5.0M
ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTIONR01DA012848 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 1999 to 2003
$4.5M
HIV and Psychiatric Comorbidity: Selected Genetic and Epigenetic FactorsR01MH079880 · NIMH · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 2006 to 2010
$3.0M
MU OPIOID RECEPTOR GENE IN HEROIN ADDICTSR01DA009444 · NIDA · UNIVERSITY OF CINCINNATI · PI YU, LEI · 1994 to 2003
$1.5M
NCATS NIH HHS UL1 TR000043NCRR NIH HHS M01 RR000102NCRR NIH HHS UL1 RR024143NIDA NIH HHS P50 DA005130NIDA NIH HHS P60 DA005130NIDA NIH HHS R01 DA009444NIDA NIH HHS R01 DA012848NIMH NIH HHS R01 MH079880
6 · The paper itself

Abstract

BACKGROUND AND

objectivesAddictions to heroin or to cocaine are associated with substantial psychiatric comorbidity, including depression. Poly-drug self-exposure (eg, to heroin, cocaine, cannabis, or alcohol) is also common, and may further affect depression comorbidity.

methodsThis case-control study examined the relationship of exposure to the above drugs and depression comorbidity. Participants were recruited from methadone maintenance clinics, and from the community. Adult male and female participants (n = 1,201) were ascertained consecutively by experienced licensed clinicians. The instruments used were the SCID-I, and Kreek-McHugh-Schluger-Kellogg (KMSK) scales, which provide a rapid dimensional measure of maximal lifetime self-exposure to each of the above drugs. This measure ranges from no exposure to high unit dose, high frequency, and long duration of exposure.

resultsA multiple logistic regression with stepwise variable selection revealed that increasing exposure to heroin or to cocaine was associated greater odds of depression, with all cases and controls combined. In cases with an opioid dependence diagnosis, increasing cocaine exposure was associated with a further increase in odds of depression. However, in cases with a cocaine dependence diagnosis, increasing exposure to either cannabis or alcohol, as well as heroin, was associated with a further increase in odds of depression. DISCUSSION AND

conclusionsThis dimensional analysis of exposure to specific drugs provides insights on depression comorbidity with addictive diseases, and the impact of poly-drug exposure. SCIENTIFIC SIGNIFICANCE: A rapid analysis of exposure to drugs of abuse reveals how specific patterns of drug and poly-drug exposure are associated with increasing odds of depression. This approach detected quantitatively how different patterns of poly-drug exposure can result in increased odds of depression comorbidity, in cases diagnosed with opioid versus cocaine dependence. (Am J Addict 2017;26:632-639).

Indexed as

DepressionSubstance-Related DisordersAdultAnalgesics, OpioidCase-Control StudiesCocaineComorbidityFemaleHeroinHumansIllicit DrugsMaleMiddle AgedPsychiatric Status Rating ScalesStatistics as TopicAnalgesics, OpioidCocaineHeroinIllicit Drugs

Identifiers

PMID28654734
PMCPMC5573655
OpenAlexW2733593915

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.